CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-28 | Kintz Samuel PRESIDENT AND CEO | Sale 10b5-1 | −5,219 | $23.57 | $123K | 100 |
| 2024-05-28 | Kintz Samuel PRESIDENT AND CEO | Sale 10b5-1 | −100 | $24.34 | $2K | 0 |
| 2024-05-28 | Kintz Samuel PRESIDENT AND CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −12,000 | 188,841 | ||
| 2024-05-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +4,250 | $2.48 | $11K | 4,250 |
| 2024-05-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,906 | $22.89 | $44K | 2,344 |
| 2024-05-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,334 | $23.42 | $55K | 10 |
| 2024-05-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10 | $24.34 | $243 | 0 |
| 2024-05-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −4,250 | 216,870 | ||
| 2024-05-16 | Heyman Richard A. Director | Sale 10b5-1 | −1,270 | $23.74 | $30K | 135,885 |
| 2024-05-16 | Gupta Rishi Director | Sale | −33,300 | $22.14 | $737K | 254,814 |
| 2024-05-16 | Gupta Rishi Director | Sale | −1,000,000 | $22.14 | $22.1M | 7,663,349 |
| 2024-05-16 | ORBIMED ADVISORS LLC Director | Sale | −33,300 | $22.14 | $737K | 254,814 |
| 2024-05-16 | ORBIMED ADVISORS LLC Director | Sale | −1,000,000 | $22.14 | $22.1M | 7,663,349 |
| 2024-05-14 | Patel Anish CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +1,107 | $2.48 | $3K | 1,107 |
| 2024-05-14 | Patel Anish CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,107 | $25.00 | $28K | 0 |
| 2024-05-14 | Patel Anish CHIEF OPERATING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,107 | 54,475 | ||
| 2024-05-09 | Patel Anish CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +260 | $2.48 | $645 | 260 |
| 2024-05-09 | Patel Anish CHIEF OPERATING OFFICER | Sale 10b5-1 | −260 | $25.06 | $7K | 0 |
| 2024-05-09 | Patel Anish CHIEF OPERATING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −260 | 55,582 | ||
| 2024-05-06 | Patel Anish CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +4,875 | $2.48 | $12K | 4,875 |
Page 20 of 42 · 825 trades